The role of amyloid β in the pathological mechanism of GNE myopathy
- PMID: 35904705
- PMCID: PMC9616754
- DOI: 10.1007/s10072-022-06301-7
The role of amyloid β in the pathological mechanism of GNE myopathy
Abstract
GNE myopathy is a hereditary muscle disorder characterized by muscle atrophy and weakness initially involving the lower distal extremities. The treatment of GNE myopathy mainly focuses on a sialic acid deficiency caused by a mutation in the GNE gene, but it has not achieved the expected effect. The main pathological features of GNE myopathy are myofiber atrophy and rimmed vacuoles, including accumulation of amyloid β, which is mainly found in atrophic muscle fibers. Although the role of amyloid β and other misfolded proteins on the nervous system has been widely recognized, the cause and process of the formation of amyloid β in the pathological process of GNE myopathy are unclear. In addition, amyloid β has been reported to be linked to quality control mechanisms of proteins, such as molecular chaperones, the ubiquitin-proteasome system, and the autophagy-lysosome system. Herein, we summarize the possible reasons for amyloid β deposition and illustrate amyloid β-mediated events in the cells and their role in muscle atrophy in GNE myopathy. This review represents an overview of amyloid β and GNE myopathy that could help identify a potential mechanism and thereby a plausible therapeutic for the disease.
Keywords: Amyloid β; Autophagy; GNE myopathy; Mitophagy; Muscle atrophy; Sialic acid.
© 2022. The Author(s).
Conflict of interest statement
The author declare no competing interests.
Figures


Similar articles
-
A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.Hum Mol Genet. 2007 Nov 15;16(22):2669-82. doi: 10.1093/hmg/ddm220. Epub 2007 Aug 18. Hum Mol Genet. 2007. PMID: 17704511
-
A Gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.Hum Mol Genet. 2007 Jan 15;16(2):115-28. doi: 10.1093/hmg/ddl446. Epub 2006 Dec 12. Hum Mol Genet. 2007. Retraction in: Hum Mol Genet. 2007 Nov 1;16(21):2647. doi: 10.1093/hmg/ddm231. PMID: 17164266 Retracted.
-
GNE myopathy caused by a synonymous mutation leading to aberrant mRNA splicing.Neuromuscul Disord. 2018 Feb;28(2):154-157. doi: 10.1016/j.nmd.2017.11.003. Epub 2017 Nov 22. Neuromuscul Disord. 2018. PMID: 29307446
-
[Development of therapy for distal myopathy with rimmed vacuoles].Rinsho Shinkeigaku. 2009 Nov;49(11):852-5. doi: 10.5692/clinicalneurol.49.852. Rinsho Shinkeigaku. 2009. PMID: 20030229 Review. Japanese.
-
Mutation update for GNE gene variants associated with GNE myopathy.Hum Mutat. 2014 Aug;35(8):915-26. doi: 10.1002/humu.22583. Hum Mutat. 2014. PMID: 24796702 Free PMC article. Review.
Cited by
-
GNE myopathy with premature ovarian failure: Case report and review of the literature.Mol Genet Metab Rep. 2025 Jul 1;44:101240. doi: 10.1016/j.ymgmr.2025.101240. eCollection 2025 Sep. Mol Genet Metab Rep. 2025. PMID: 40687627 Free PMC article.
-
Muscular Swedish mutant APP-to-Brain axis in the development of Alzheimer's disease.Cell Death Dis. 2022 Nov 10;13(11):952. doi: 10.1038/s41419-022-05378-4. Cell Death Dis. 2022. PMID: 36357367 Free PMC article.
-
Ion Mobility QTOF-MS Untargeted Lipidomics of Human Serum Reveals a Metabolic Fingerprint for GNE Myopathy.Molecules. 2024 Nov 4;29(21):5211. doi: 10.3390/molecules29215211. Molecules. 2024. PMID: 39519852 Free PMC article.
References
-
- Pogoryelova O, Cammish P, Mansbach H, Argov Z, Nishino I, Skrinar A, Chan Y, Nafissi S, Shamshiri H, Kakkis E, Lochmüller H. Phenotypic stratification and genotype-phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: first report from the GNE myopathy Disease Monitoring Program, registry portion. Neuromuscul Disord : NMD. 2018;28(2):158–168. doi: 10.1016/j.nmd.2017.11.001. - DOI - PMC - PubMed
-
- Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, Barash M, Shemesh M, Sadeh M, Grabov-Nardini G, Shmilevich I, Friedmann A, Karpati G, Bradley WG, Baumbach L, Lancet D, Asher EB, Beckmann JS, Argov Z, Mitrani-Rosenbaum S. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet. 2001;29(1):83–87. doi: 10.1038/ng718. - DOI - PubMed
-
- Hinderlich S, Stäsche R, Zeitler R, Reutter W. A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. J Biol Chem. 1997;272(39):24313–24318. doi: 10.1074/jbc.272.39.24313. - DOI - PubMed
-
- Krause S, Hinderlich S, Amsili S, Horstkorte R, Wiendl H, Argov Z, Mitrani-Rosenbaum S, Lochmüller H. Localization of UDP-GlcNAc 2-epimerase/ManAc kinase (GNE) in the Golgi complex and the nucleus of mammalian cells. Exp Cell Res. 2005;304(2):365–379. doi: 10.1016/j.yexcr.2004.11.010. - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical